NEWS & VIEWS

Global private equity and venture capital news and research

Avista Capital takes on ex Nycomed CEO

7 Oct 2011

New York-based private equity firm Avista Capital Partners has hired former Nycomed CEO Hakan Bjorklund as a healthcare operating executive.

Bjorklund worked closely with Avista on the development of Nycomed during the firm’s ownership of the company, which was recently sold to Japanese pharmaceutical giant Takeda for €9.6bn- the largest pharmaceutical exit this year.

Under Bjorklund’s leadership, Nycomed was transformed from a predominantly Scandinavian business into a global pharmaceutical company with leading market positions in Europe, Russia and CIS, Brazil and Latin America.

In 2006 he led the integration of Altana Pharmaceutical, a German-based company that Nycomed purchased for €4.2bn. He was also instrumental in growing Nycomed in emerging markets, most recently through last year’s acquisition of Guangdong Techpool Bio-Pharma, a fast-growing Chinese bio-pharmaceutical company.

Before joining Nycomed, Bjorklund was regional director at Astra (now AstraZeneca) and, earlier, president of Astra Draco. He is a member of the board of directors of Coloplast, Lundbeck, and Atos Medical. He was also a director at Danisco until its recent acquisition by Dupont.

“We are delighted to welcome Hakan to Avista. One of the top pharmaceutical executives in Europe, he possesses a deep understanding of the global healthcare market,” said Thompson Dean, co-managing partner and CEO of Avista.

Takeda acquired Nycomed in May for €9.6bn in cash. The boards of both companies unanimously approved the deal, giving Takeda a strong platform in Europe and emerging markets.

Copyright © 2011 AltAssets

FUNDRAISING & INVESTOR RELATIONS

Join the Private Equity & VC Fundraising & IR Group on LinkedIn. For LPs and GPs with an interest in private equity and venture capital fundraising, investor relations and marketing.

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014